{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T03:13:24Z","timestamp":1792206804046,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.vaccine.2023.06.042","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T12:51:01Z","timestamp":1686833461000},"page":"4658-4665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink"],"prefix":"10.1016","volume":"41","author":[{"given":"Tat'Yana A.","family":"Kenigsberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5117-8279","authenticated-orcid":false,"given":"Kayla E.","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola P.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8380-6215","authenticated-orcid":false,"given":"Ousseny","family":"Zerbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4750-7672","authenticated-orcid":false,"given":"Stanley","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Katherine","family":"Yih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7437-6797","authenticated-orcid":false,"given":"Stephanie A.","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4699-8497","authenticated-orcid":false,"given":"Laura P.","family":"Hurley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason M.","family":"Glanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1785-0218","authenticated-orcid":false,"given":"Lisa A.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0375-0504","authenticated-orcid":false,"given":"Eric S.","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.06.042_b0005","unstructured":"U.S. Food and Drug Administration. COVID-19 Vaccines; Accessed December 27, 2022, from https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines."},{"key":"10.1016\/j.vaccine.2023.06.042_b0010","unstructured":"U.S. Food and Drug Administration. COVID-19 Vaccines; Accessed April 29, 2022, from https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/covid-19-vaccines."},{"key":"10.1016\/j.vaccine.2023.06.042_b0015","unstructured":"Centers for Disease Control and Prevention. Vaccine Recommendations and Guidelines of the ACIP. Timing and Spacing of Immunobiologics; Accessed October 28, 2022, from https:\/\/www.cdc.gov\/vaccines\/hcp\/acip-recs\/general-recs\/timing.html."},{"key":"10.1016\/j.vaccine.2023.06.042_b0020","unstructured":"Kroger A, Bahta L, Long S, Sanchez P. General best practice guidelines for immunization. Best practices guidance of the Advisory Committee on Immunization Practices (ACIP)."},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.042_b0025","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2084","article-title":"Safety of quadrivalent meningococcal conjugate vaccine in 11- to 21-Year-Olds","volume":"139","author":"Tseng","year":"2017","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.042_b0030","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/j.vaccine.2012.01.027","article-title":"Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010\u20132011","volume":"30","author":"Tse","year":"2012","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.042_b0035","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/pds.3996","article-title":"Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013\u20132014 and 2014\u20132015 seasons","volume":"25","author":"Li","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.vaccine.2023.06.042_b0040","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.vaccine.2020.01.046","article-title":"The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines","volume":"38","author":"Baker","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.06.042_b0045","unstructured":"ACIP COVID-19 Vaccines Work Group Interpretations of Data; Accessed April 29, 2022, from https:\/\/www.cdc.gov\/vaccines\/acip\/meetings\/downloads\/slides-2021-01\/10-COVID-Oliver.pdf."},{"key":"10.1016\/j.vaccine.2023.06.042_b0050","unstructured":"Centers for Disease Control and Prevention. Interim clinical considerations for use of COVID-19 vaccines currently approved or authorized in the United States. US Department of Health and Human Services, CDC; 2022. Accessed October 10, 2022, from https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html."},{"issue":"5152","key":"10.1016\/j.vaccine.2023.06.042_b0055","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.15585\/mmwr.mm705152a1","article-title":"COVID-19 vaccine safety in children aged 5\u201311 years - United States, November 3-December 19, 2021","volume":"70","author":"Hause","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.042_b0060","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2022-057313","article-title":"Safety of COVID-19 vaccination in United States children ages 5 to 11 years","volume":"150","author":"Hause","year":"2022","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2023.06.042_b0065","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S2213-2600(21)00409-4","article-title":"Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial","volume":"10","author":"Toback","year":"2022","journal-title":"Lancet Respir Med"},{"issue":"10318","key":"10.1016\/j.vaccine.2023.06.042_b0070","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1016\/S0140-6736(21)02329-1","article-title":"Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial","volume":"398","author":"Lazarus","year":"2021","journal-title":"Lancet (London, England)"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2023.06.042_b0075","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1542\/peds.2010-1722H","article-title":"The Vaccine Safety Datalink: a model for monitoring immunization safety","volume":"127","author":"Baggs","year":"2011","journal-title":"Pediatrics"},{"issue":"42","key":"10.1016\/j.vaccine.2023.06.042_b0080","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"issue":"36","key":"10.1016\/j.vaccine.2023.06.042_b0085","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1016\/j.vaccine.2015.07.037","article-title":"Demographic characteristics of members of the Vaccine Safety Datalink (VSD): A comparison with the United States population","volume":"33","author":"Sukumaran","year":"2015","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2023.06.042_b0090","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.vaccine.2021.12.048","article-title":"Monitoring vaccine safety using the vaccine safety Datalink: Assessing capacity to integrate data from Immunization Information systems","volume":"40","author":"Groom","year":"2022","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2023.06.042_b0095","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1001\/jama.2021.15072","article-title":"Surveillance for adverse events after COVID-19 mRNA vaccination","volume":"326","author":"Klein","year":"2021","journal-title":"JAMA"},{"issue":"10 Supl 2","key":"10.1016\/j.vaccine.2023.06.042_b0100","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1097\/MLR.0b013e3180616c0a","article-title":"Real-time vaccine safety surveillance for the early detection of adverse events","volume":"45","author":"Lieu","year":"2007","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2023.06.042_b0105","unstructured":"Centers for Disease Control and Prevention. International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM). Accessed August 31, 2022, from https:\/\/www.cdc.gov\/nchs\/icd\/icd-10-cm.htm."},{"key":"10.1016\/j.vaccine.2023.06.042_b0110","doi-asserted-by":"crossref","DOI":"10.1177\/20420986211021233","article-title":"Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination","volume":"12","author":"Naleway","year":"2021","journal-title":"Therap Adv Drug Safety"},{"key":"10.1016\/j.vaccine.2023.06.042_b0115","unstructured":"Vaccine Safety Datalink. Rapid Cycle Analysis (RCA) to monitor the safety of COVID-19 vaccines in near real-time within the Vaccine Safety Datalink protocol. Accessed January 3, 2023. https:\/\/www.cdc.gov\/vaccinesafety\/pdf\/VSD-COVID19-RCA-Protocol-508.pdf."},{"key":"10.1016\/j.vaccine.2023.06.042_b0120","doi-asserted-by":"crossref","unstructured":"U.S. Food and Drug Administration. Comirnaty and Pfizer\u2010BioNTech COVID\u201019 vaccine. Published 2022. Accessed December 12, 2022, from https:\/\/www.fda.gov\/emergency-preparedness-and-response\/coronavirus-disease-2019-covid-19\/comirnaty-and-pfizer-biontech-covid-19-vaccine#additional.","DOI":"10.1007\/s40278-022-16299-8"},{"issue":"6","key":"10.1016\/j.vaccine.2023.06.042_b0125","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1001\/jamainternmed.2022.1222","article-title":"Risk of appendicitis after mRNA COVID-19 vaccination in a Danish population","volume":"182","author":"Kildegaard","year":"2022","journal-title":"JAMA Int Med"},{"issue":"28","key":"10.1016\/j.vaccine.2023.06.042_b0130","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1016\/j.vaccine.2021.05.016","article-title":"U.S. Population-Based background incidence rates of medical conditions for use in safety assessment of COVID-19 vaccines","volume":"39","author":"Gubernot","year":"2021","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2023.06.042_b0135","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1046\/j.1528-1157.2002.t01-1-26901.x","article-title":"Systematic review and meta-analysis of incidence studies of epilepsy and unprovoked seizures","volume":"43","author":"Kotsopoulos","year":"2002","journal-title":"Epilepsia"},{"issue":"27","key":"10.1016\/j.vaccine.2023.06.042_b0140","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2023.06.042_b0145","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1001\/jamainternmed.2021.2219","article-title":"Association of facial paralysis with mRNA COVID-19 vaccines: a disproportionality analysis using the world health organization pharmacovigilance database","volume":"181","author":"Renoud","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.vaccine.2023.06.042_b0150","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1473-3099(21)00451-5","article-title":"Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study","volume":"22","author":"Wan","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2023.06.042_b0155","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2023.06.042_b0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/pds.998","article-title":"A potential signal of Bell's palsy after parenteral inactivated influenza vaccines: reports to the Vaccine Adverse Event Reporting System (VAERS)\u2013United States, 1991\u20132001","volume":"13","author":"Zhou","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.vaccine.2023.06.042_b0165","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/j.vaccine.2012.01.013","article-title":"The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis","volume":"30","author":"Huang","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2023.06.042_b0170","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s40264-020-00967-8","article-title":"Determining which of several simultaneously administered vaccines increase risk of an adverse event","volume":"43","author":"Wang","year":"2020","journal-title":"Drug Saf"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300717X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X2300717X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:28:40Z","timestamp":1759404520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X2300717X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":34,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S0264410X2300717X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.042","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety of simultaneous vaccination with COVID-19 vaccines in the Vaccine Safety Datalink","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.06.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}